YbaƱez, Ruben D.
HRN: 23-88-89 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/13/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
10/13/2023
10/19/2023
IVTT
4.5g
Q8
Cap HR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes